These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 26574877)

  • 1. Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms?
    Cornu JN; Grise P
    Curr Opin Urol; 2016 Jan; 26(1):17-21. PubMed ID: 26574877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can we predict and manage persistent storage and voiding LUTS following bladder outflow resistance reduction surgery in men? ICI-RS 2023.
    Tarcan T; Hashim H; Malde S; Sinha S; Sahai A; Acar O; Selai C; Agro EF; Abrams P; Wein A
    Neurourol Urodyn; 2024 Aug; 43(6):1447-1457. PubMed ID: 38477358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of bladder vascular resistance before and after prostatic surgery in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Wada N; Watanabe M; Kita M; Matsumoto S; Kakizaki H
    Neurourol Urodyn; 2012 Jun; 31(5):659-63. PubMed ID: 22488529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
    Drake MJ; Chapple C; Sokol R; Oelke M; Traudtner K; Klaver M; Drogendijk T; Van Kerrebroeck P;
    Eur Urol; 2015 Feb; 67(2):262-70. PubMed ID: 25070148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM) for diagnosis and management of bladder outlet obstruction in men: study protocol for a randomised controlled trial.
    Bailey K; Abrams P; Blair PS; Chapple C; Glazener C; Horwood J; Lane JA; McGrath J; Noble S; Pickard R; Taylor G; Young GJ; Drake MJ; Lewis AL
    Trials; 2015 Dec; 16():567. PubMed ID: 26651344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of persistent storage symptoms after transurethral resection of the prostate in patients with benign prostatic enlargement.
    Choi H; Kim JH; Shim JS; Park JY; Kang SH; Moon du G; Cheon J; Lee JG; Kim JJ; Bae JH
    Urol Int; 2014; 93(4):425-30. PubMed ID: 25300422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
    Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
    Silva J; Silva CM; Cruz F
    Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
    Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
    Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective impacts of tadalafil on storage and voiding function in male patients with benign prostatic hyperplasia: 1-year outcomes from a prospective urodynamic study.
    Matsukawa Y; Takai S; Majima T; Funahashi Y; Sassa N; Kato M; Yamamoto T; Gotoh M
    World J Urol; 2019 May; 37(5):867-872. PubMed ID: 30121825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment.
    Jiang YH; Wang CC; Kuo HC
    PLoS One; 2018; 13(2):e0190704. PubMed ID: 29462145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
    Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ;
    Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detrusor underactivity in men with lower urinary tract symptoms/benign prostatic obstruction: characterization and potential impact on indications for surgical treatment of the prostate.
    Rademakers KL; van Koeveringe GA; Oelke M
    Curr Opin Urol; 2016 Jan; 26(1):3-10. PubMed ID: 26574876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urodynamic findings in young men with chronic lower urinary tract symptoms.
    Karami H; Valipour R; Lotfi B; Mokhtarpour H; Razi A
    Neurourol Urodyn; 2011 Nov; 30(8):1580-5. PubMed ID: 21780163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of medical therapy or surgery on prostatic and bladder resistive indices in patients with benign prostatic hyperplasia.
    Bulut S; Ozden C; Aktas BK; Deren T; Tagci S; Gokkaya CS; Baykam MM; Memis A
    Urol Int; 2015; 94(2):181-6. PubMed ID: 25139617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial.
    Kaplan SA; He W; Koltun WD; Cummings J; Schneider T; Fakhoury A
    Eur Urol; 2013 Jan; 63(1):158-65. PubMed ID: 22831853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis of benign prostatic obstruction: Development of a clinical nomogram.
    De Nunzio C; Autorino R; Bachmann A; Briganti A; Carter S; Chun F; Novara G; Sosnowski R; Thiruchelvam N; Tubaro A; Ahyai S;
    Neurourol Urodyn; 2016 Feb; 35(2):235-40. PubMed ID: 25524269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Male non-neurogenic overactive bladder].
    Phé V; Gamé X
    Prog Urol; 2020 Nov; 30(14):880-886. PubMed ID: 33220816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of sexual function when relieving benign prostatic obstruction surgically: can a trade-off be considered?
    Chung A; Woo HH
    Curr Opin Urol; 2016 Jan; 26(1):42-8. PubMed ID: 26555693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.